ModelEdge

Ligand Pharmaceuticals Inc
LGND
Filing Type425
Filing Date10/2/2022
Updated10/3/22, 3:20 AM

Filing

425
Earnings Release

Exhibits

425Prospectus Filed Pursuant to Rule 425
GRAPHICGraphic